Trials
Search / Trial NCT05645939

Association of Obesity and Cardiovascular Outcomes in Hypertrophic Cardiomyopathy

Launched by AJOU UNIVERSITY SCHOOL OF MEDICINE · Dec 2, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Recruiting

Keywords

Hypertrophic Cardiomyopathy Obesity Paradox

ClinConnect Summary

This clinical trial is studying how obesity affects heart health in patients with a condition called hypertrophic cardiomyopathy (HCM), which makes the heart muscle thicker than normal. Researchers want to understand the relationship between body weight and waist size and how these factors impact heart-related issues in Asian patients with HCM. The trial is currently recruiting participants who were newly diagnosed with HCM between January 2015 and December 2020.

To be eligible for this study, patients must be at least 20 years old and have received their HCM diagnosis within the specified timeframe. Unfortunately, those who were diagnosed before 2015 or have cancer cannot participate. If you join the trial, you will be part of a larger effort to learn more about how obesity influences heart health in people with HCM, which could help improve treatment and outcomes for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patients newly diagnosed with HCMP between January 2015 and December 2020
  • Exclusion Criteria:
  • • Patients aged \<20 years
  • • Patients diagnosed with HCMP before 2015
  • • Patients with cancer

Trial Officials

Kwang-No LEE

Study Chair

Ajou University School of Medicine

About Ajou University School Of Medicine

Ajou University School of Medicine is a leading academic institution dedicated to advancing medical research and education. Located in South Korea, the School of Medicine is renowned for its commitment to innovative clinical trials that aim to improve patient outcomes and enhance healthcare practices. With a focus on multidisciplinary collaboration, Ajou University fosters a research environment that integrates cutting-edge technologies and scientific inquiry. The institution is dedicated to ethical standards and regulatory compliance, ensuring the safety and welfare of participants in all clinical studies. Through its robust training programs and partnerships, Ajou University School of Medicine aims to contribute significantly to the global medical community.

Locations

Suwon, Gyeong Gido, Korea, Republic Of

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials